Generic Price Competition For Specialty Drugs: Too Little, Too Late? | Health Affairs
Generic Drug Policies for Developing Countries
Competition and price among brand-name drugs in the same class: A systematic review of the evidence | PLOS Medicine
Does Entry Remedy Collusion? Evidence From the Generic Prescription Drug Cartel | BFI
PDF) Entry Barriers to Generic Medicines in Malaysia: Policy Implications for Drug Affordability and Accessibility
Generic Competition and Drug Prices | FDA
Competition's role in controlling prescription drug prices - Equitable Growth
U.S. Consumers Overpay for Generic Drugs – USC Schaeffer
PDF) The Empirical Effect of Generic Competition on Brand-Name Molecules in the U.S. Pharmaceutical Market | Nicholas Debany - Academia.edu
How Generic Drugs, Patents, and Price Controls Affect Markets | NBER
Prescription Drugs: Spending, Use, and Prices | Congressional Budget Office
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class – DrugPatentWatch - Make Better Decisions
Patent Expiration and Pharmaceutical Prices | NBER
The effect of inertia on brand-name versus generic drug choices - ScienceDirect
Limiting Evergreening for Name-Brand Prescription Drugs | Committee for a Responsible Federal Budget
The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar
The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study - The Lancet Public Health
Does NICE influence the adoption and uptake of generics in the UK? | SpringerLink
Generic Drug Regulation and Pharmaceutical Price-Jacking - Marginal REVOLUTION
The unexpected consequences of generic entry - ScienceDirect
Getting to the Root of High Prescription Drug Prices
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley Online Library
